The largest database of trusted experimental protocols

Psilencer 4.1 cmv neo plasmid

Manufactured by Thermo Fisher Scientific
Sourced in United States

The pSilencer 4.1-CMV/neo plasmid is a vector designed for the expression of small interfering RNA (siRNA) in mammalian cells. It contains a cytomegalovirus (CMV) promoter for driving siRNA expression and a neomycin resistance gene for selection of transfected cells.

Automatically generated - may contain errors

4 protocols using psilencer 4.1 cmv neo plasmid

1

Construction and Validation of OR3A4 and PDLIM2 Expression Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression vectors for human OR3A4 and PDLIM2 were constructed using PCR methods. The PCR products were confirmed by direct DNA sequencing and cloned into the mammalian expression vectors pEGFP-N1 and pcDNA 3.0 as previously described [3 (link)]. The siRNA expression vector, the pSilencer 4.1-CMV/neo plasmid (Invitrogen Corp, Carlsbad, CA, USA), was used for cloning small synthetic oligonucleotides. Two sequences unique to the coding region of OR3A4 were designed and inserted between the BamHI and HindIII sites of the pSilencer 4.1-CMV/neo plasmid. The primers used to construct the three vectors are listed in Supplementary Table S2. MKN-45 and NCI-N87 gastric cancer cell lines were used for overexpression and knockdown studies. For transfection, complexes of Lipofectamine 2000 (Invitrogen) and the desired plasmid were prepared according to the manufacturer's instructions. We obtained stably transfected clones by G418 selection (Promega, Madison, WI, USA). The level of OR3A4 expression after transfection was assayed by RT-PCR. A stable transfectant of the empty vector was used as a control.
+ Open protocol
+ Expand
2

Overexpression and Knockdown of MSTO2P in Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MSTO2P sequences were synthesized and subcloned into the pcDNA3.1 (Invitrogen, Shanghai, China) vector. The siRNA expression vector, the pSilencer 4.1-CMV/neo plasmid (Invitrogen Corp, Carlsbad, CA, USA), was used for cloning small synthetic oligonucleotides. Stability-enhanced precursor, miR-335miRNA inhibitor, and negative control RNA-oligonucleotides were purchased from Ambion Corporation (Austin, TX, USA). NCI-N87 and SGC-7901 gastric cancer cell lines were used for overexpression and knockdown studies. For transfection, complexes of Lipofectamine 2000 (Invitrogen) and the desired plasmid were prepared according to the manufacturer's instructions. We obtained stably transfected clones by G418 selection (Promega, Madison, WI, USA). The level of MSTO2P and miR-335 expression after transfection was assayed by RT-PCR. A stable transfectant of the empty vector was used as a control, and these complexes were directly mixed with cells in 24-well cell culture plates at a density of 4 × 10 4 cells per well.
+ Open protocol
+ Expand
3

siRNA Plasmid Construction and In Vivo Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
To construct a siRNA expression plasmid (P-422), a 21 nt siRNA sequence (5′-ATGGGCATTAATTGCATGCAT-3′) was designed at Whitehead (http://sirna.wi.mit.edu/) to target the SjAlstR gene. On the basis of this 21 nt target sequence, two complementary 55 nt siRNA template oligonucleotides were designed, synthesized, annealed and ligated into P-silencer 4.1-CMV neo plasmid (Ambion, USA). A control, scrambled sequence (5′-GCGAGTACCTTGTTAGATATA-3′) was cloned into P-silencer4.1-CMV neo to serve as a negative control (P-S422).
For each mouse at 20 d.p.i., a 1.5 ml transfection mixture, which contained 0.9% NaCl, 100 μg plasmid DNA and 150 μg PEI (AparnaBio, USA), was injected via tail vein. After maintenance of these mice for the subsequent 72 h, the mice were killed. The females in paired worms were collected for qRT–PCR investigation and for visual examination using light microscopy and CLSM. Mice that were not subjected to the injection of test compounds served as controls. Five independent experiments were performed.
+ Open protocol
+ Expand
4

Silencing NRP1 in DJM-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The designed shNRP1 oligonucleotide sequences were based on siNRP1 #3. Sense oligo: 5′-GATCCCGGGCTGAGGATTGTACAGTTCAAGAGACTGTACAATCCTCAGCCCGTCA-3′, antisense oligo: 5′-AGCTTGACGGGCTGAGGATTGTACAGTCTCTTGAACTGTACAATCCTCAGCCCGG-3′. The sense and antisense oligonucleotides were annealed and inserted at the BamHI and HindIII restriction sites into the pSilencer™ 4.1-CMV neo plasmid (Ambion; Life Technologies). DJM-1 cells were transfected with the shNRP1 construct or control plasmid by electroporation with a 0.4 cm cuvette (GenePulser Xcell; Bio-Rad). The transfectants were screened in 400 µg/ml G418-contained growth medium to obtain stable DJM-1 cell clones (shNRP1 clone #12 and #13, shControl).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!